Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
Tickers BIIB ESALF ESALY
Tags Market News ESALF Briefs
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags FDA Benzinga Penny Stocks
From Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
Tickers BIIB CEMI ESALY EYEN
Tags Benzinga FDA Penny Stocks
From Benzinga
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
Tickers ESALF ESALY MRK
Tags Biotech ESALY News
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
Tickers ALKS AMGN ARGX BGNE
Tags NVAX Small Cap News
From Benzinga
Merck Snags Yet Another Indication for This Drug Combo
Tickers ESALY MRK
Tags Market News Recent Press Releases MRK
From Motley Fool
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags Government Biotech why it's moving
From Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
Tickers BIIB ESALF ESALY
Tags Market News Briefs General
From Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
Tickers ESALF ESALY MRK
Tags News ESALY Biotech
From Benzinga
Why Are Biogen Shares Gaining Today?
Tickers BIIB ESALF ESALY
Tags Briefs General ESALF
From Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
Tickers BIIB ESALF ESALY
Tags Health Care Benzinga ESALY
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
Tickers APTO APYX BIIB BLFS
Tags TIVC ELDN ESALY
From Benzinga
3 Big Problems With Biogen's Q3 Results
Tickers BIIB ESALY SAGE
Tags Market News ESALY SAGE
From Motley Fool
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Biotech Alzheimer's disease ESALY
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Tickers AFIB ALT AMZN APYX
Tags PFE AMZN AXDX
From Benzinga
How Keytruda's Latest Approval in China Boosts Merck
Tickers ESALY MRK
Tags Market News ESALY MRK
From Motley Fool
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
Tickers CTXR ESALY RDY
Tags General RDY Price Target
From Benzinga
Merck Investors Have Reason to Cheer This Label Expansion
Tickers ESALY MRK
Tags Market News MRK ESALY
From Motley Fool
Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma
Tickers ESALF ESALY RDY
Tags Market News ESALF RDY
From Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Tickers ABSI AGEN ALKS AXNX
Tags LGND ORPH KZR
From Benzinga
Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free
Tickers BIIB ESALF ESALY
Tags Health Care Benzinga Alzheimer's disease
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
Tickers ADGI ASND BNR BNTX
Tags ASND IPOs News
From Benzinga
What This Label Expansion Means for Merck
Tickers ESALY MRK PFE
Tags PFE ESALY MRK
From Motley Fool
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
Tickers BIIB ESALF ESALY
Tags Market News COVID/19 Coronavirus Alzheimer’s
From Benzinga
Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei's
Tickers BIIB ESALF ESALY
Tags ESALF General Briefs
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Tickers ABSI AXSM BIOC BNTX
Tags Biotech Earnings BNTX
From Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Tickers ABCL ACET ACHV ADGI
Tags HARP EWTX OTIC
From Benzinga
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
Tickers BIIB ESALF ESALY
Tags Market News ESALF General
From Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
Tickers ALBO AXSM CARA CCXI
Tags CARA IBB News
From Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Tickers ABBV ABSI ACET ALKS
Tags ALNY IMGN TECH
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.